In brief
- The Governor of Delaware has signed SB 249, establishing a state licensing system for harm reduction programs.
- The law removes personal-use drug paraphernalia—including substance testing equipment—from the criminal code.
- An accompanying executive order conditions the expansion of funding on measurable health outcomes.
The state of Delaware, on the U.S. East Coast, has enacted a law this week that formalizes and provides legal protection for harm reduction. Governor Matt Meyer signed SB 249, alongside an executive order dated September 30 that sets the timeline for its implementation.
What the law changes
SB 249 tasks the state’s Division of Substance Abuse and Mental Health with licensing public programs that distribute harm reduction supplies. The list includes syringes and needles, but also extends to other items such as filters, sterile water, mouthpieces, and straws, ensuring the scope is not limited solely to those who inject drugs.
The law also modifies the definition of paraphernalia. Possession of such materials for personal use is no longer a crime, while prohibitions remain in place for items used to manufacture or distribute drugs. According to local reporting, tools used to check the content of a substance—such as test strips for fentanyl, xylazine, or medetomidine—are also excluded from the definition of paraphernalia.
The bill was introduced on March 5, passed the Senate on May 14, and cleared the House of Representatives on June 23. Republican lawmakers opposed the decriminalization of paraphernalia and the expansion of distributed materials beyond syringes.
Executive Order 28: Constraints and timeline
The order, dated September 30, directs the Department of Health and Social Services to draft evidence-based regulations. Implementation will occur in phases. The first phase integrates existing services—such as syringe exchange, naloxone distribution, disease screening, and drug checking materials—into the new framework without interrupting their operations.
The second phase, which involves expanding state funding to categories with more recent evidence, will only proceed following a written determination that previous efforts yielded positive health outcomes “without significant unintended harms.” Baseline indicators must be established to monitor overdoses, disease transmission, emergency room visits, and community safety. The governor will receive annual reports, and corrective measures are planned if overdose deaths or infection rates increase.
A manager of an overdose prevention program cited by Delaware Public Media deemed the oversight reasonable, noting that it allows for course correction and mandates accountability for both the entities and the state.
What it implies
Two points are worth distinguishing. First, the law provides legal security to those working in the field and to the people who use these services: possessing a testing kit or a mouthpiece is no longer a criminal offense in itself. Second, the actual impact will depend on the regulations, which have yet to be written, and on what is funded and when. The executive order makes it clear that supplies with less scientific backing will have to wait.
This is a recent legislative change, and data on its effects are not yet available. The text does not address supervised consumption sites; it focuses on supplies and licensing. For those looking to contextualize this debate, the harm reduction and responsible use guide explains existing tools and the evidence behind each, while the psychedelics map covers the regulatory context of these substances.
Source
- Governor Matt Meyer, State of Delaware. Executive Order 28. Office of the Governor of Delaware, September 30, 2026.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
